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We constructed a complete panel of alanine mutants
of the insect-specific calcium channel blocker -atraco-
toxin-Hv1a. Lethality assays using these mutant toxins
identified three spatially contiguous residues, Pro10,
Asn27, and Arg35, that are critical for insecticidal activ-
ity against flies (Musca domestica) and crickets (Acheta
domestica). Competitive binding assays using radiola-
beled -atracotoxin-Hv1a and neuronal membranes pre-
pared from the heads of American cockroaches (Peripla-
neta americana) confirmed the importance of these
three residues for binding of the toxin to target calcium
channels presumably expressed in the insect mem-
branes. At concentrations up to 10 M, -atracotoxin-
Hv1a had no effect on heterologously expressed rat
Cav2.1, Cav2.2, and Cav1.2 calcium channels, consistent
with the previously reported insect selectivity of the
toxin. 30 M -atracotoxin-Hv1a inhibited rat Cav cur-
rents by 10–34%, depending on the channel subtype, and
this low level of inhibition was essentially unchanged
when Asn27 and Arg35, which appears to be critical for
interaction of the toxin with insect Cav channels, were
both mutated to alanine. We propose that the spatially
contiguous epitope formed by Pro10, Asn27, and Arg35
confers specific binding to insect Cav channels and is
largely responsible for the remarkable phyletic selectiv-
ity of -atracotoxin-Hv1a. This epitope provides a struc-
tural template for rational design of chemical insecti-
cides that selectively target insect Cav channels.
The first peptide neurotoxins isolated from the venom of
Australian funnel-web spiders (genera Atrax and Hadronyche)
and shown to have selective activity against insects were mem-
bers of the -atracotoxin-1 (ACTX)1 family (1–3). These toxins
comprise 36–37 residues with six strictly conserved cysteine
residues that are paired to form three disulfide bridges (4). The
best studied family member, -ACTX-Hv1a, is one of the most
potent insecticidal peptide toxins discovered so far (4, 5); it has
proved lethal to all insect orders that have been tested, includ-
ing coleopterans, dictyopterans, hemipterans, orthopterans,
and refractory lepidopteran pests such as the tobacco budworm
Heliothis virescens and the cotton bollworm Helicoverpa
armigera (1, 2, 5).
The phyletic specificity of these toxins appears to reside in
their ability to block insect, but not vertebrate, voltage-gated
calcium channels (2). Although nanomolar concentrations of
-ACTX-Hv1a are sufficient to block high voltage-activated
(HVA) calcium currents in the central nervous system of the
fruit fly Drosophila melanogaster and the American cockroach
Periplaneta americana (2, 5), 1 M toxin does not block HVA
calcium currents in vertebrate neurons (2) and the toxin is
harmless when injected subcutaneously into newborn mice (1).
With the exception of the organophosphate and carbamate
insecticides (which target acetylcholinesterase), the vast ma-
jority of synthetic insecticides are directed against voltage-
gated sodium channels, nicotinic acetylcholine receptors, or
GABA/glutamate-gated chloride channels. This limited group
of targets has promoted the evolution of cross-resistance to
different families of insecticides (6) and stimulated interest in
the development of new insecticides that act on targets outside
of this established ion channel triumvirate (7). Although block-
ers of HVA calcium currents have evolved independently in the
venoms of cone snails, snakes, and spiders (4, 8, 9), no com-
mercially available insecticide exploits this target (7, 10). Thus,
-ACTX-Hv1a is a valuable lead for the development of a new
class of insecticides that target insect calcium channels.
The three-dimensional structure of -ACTX-Hv1a comprises
a disulfide-rich globular core (residues 4–21), with residues
22–37 forming a finger-like  hairpin that protrudes from this
globular region (2). In a previous structure-activity relation-
ship study, we demonstrated the functional significance of sev-
eral residues in the toxin’s  hairpin (11). In the present study,
we extended our scanning mutagenesis of -ACTX-Hv1a in
several ways: first, we employed a complete panel of alanine
mutations representing all solvent-exposed side chains of the
toxin structure; second, we tested these mutations using lethal-
ity assays performed in two distantly related insects, the or-
thopteran Acheta domestica and the dipteran Musca domestica;
third, by performing competitive binding assays using a neu-
ronal membrane preparation from the head of P. americana, we
obtained information about the toxin-target interaction that is
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not complicated by issues of bioavailability and/or pharmaco-
kinetics. The data indicate that a spatially contiguous epitope
composed of residues Pro10, Asn27, and Arg35 is responsible for
the specific interaction of this toxin with insect calcium chan-
nels. A panel of follow-up mutants was used to ascertain the
key chemical features of these residues that are critical for the
toxin-channel interaction. This information should facilitate
the rational design of chemical insecticides based on the struc-
ture of -ACTX-Hv1a.
EXPERIMENTAL PROCEDURES
Production of -ACTX-Hv1a Mutants—Individual point mutations
were introduced into a synthetic gene encoding -ACTX-Hv1a as de-
scribed previously (11) using either 1) mutagenic PCR using the C2
primer, a mutagenic version of the N1 primer (with pHWT1 as a
template), or 2) overlap extension PCR using a pair of complementary
mutagenic primers in combination with the original N1 and C2 primers
(with pHWT1 as a template). The full-length product of the mutagenic
PCR was then digested with EcoRI and BamHI and subcloned into the
expression vector pGEX-2T as described previously for pHWT-1 (11).
Double mutations were introduced by a similar process in which a
version of pHWT-1 encoding one of the two desired mutations was used
as the PCR template. Overexpression and purification of recombinant
wild-type (WT) -ACTX-Hv1a and mutants thereof was performed as
described previously using glutathione affinity chromatography fol-
lowed by C18 reverse-phase high pressure liquid chromatography (11).
The identity of each toxin was confirmed using electrospray mass
spectrometry.
Insect Toxicity Assays—Insecticidal activity was tested as described
previously (11, 12) by injecting peptides dissolved in insect saline (13)
into house crickets (Acheta domestica) or house flies (Musca domestica).
LD50 values (i.e. the dose that is lethal to 50% of insects) were calcu-
lated as described previously (11), and the reported values are the mean
of two to three independent experiments.
CD Spectroscopy—CD spectra of -ACTX-Hv1a or mutants thereof
were collected and processed as described previously using a Jasco
J-715 spectropolarimeter (11). The toxin concentration was 15 M.
Radiolabeling of Recombinant -ACTX-Hv1a—Lethality assays per-
formed with crickets showed that although mutation of Tyr to Phe at
residue 13 of -ACTX-Hv1a was not deleterious, other mutations at this
residue (such as Tyr to Trp or Ala) can lower toxin activity (see “Re-
sults”). Hence, Tyr13 is not a good target for iodination. Because the
initial alanine scan of the -hairpin region of -ACTX-Hv1a (11) re-
vealed that an F24A mutation was tolerated, we decided to engineer a
“YF swap mutant,” in which Tyr13 was mutated to Phe and Phe24 was
mutated to Tyr, for use as a radioiodination substrate. The swap mu-
tant was fully functional in LD50 assays and it contained a single,
non-critical Tyr residue (Tyr24) that allowed radioactive iodine to be
conjugated to residue 24 rather than to residue 13. Radioiodination of
the YF swap mutant was performed as described previously for -cono-
toxin GVIA (14) except for minor changes in the reverse-phase high
pressure liquid chromatography method used to purify the radiolabeled
toxin. The purification was performed using a Vydac C18 analytical
reverse-phase column (4.6  250 mm; 5 m pore size) eluted at 1
ml/min using a linear gradient of 0–28% buffer B (0.085% trifluoroace-
tic acid and 50% acetonitrile in water) in buffer A (0.1% trifluoroacetic
acid in water) over 5 min, followed by a linear gradient of 28–35% buffer
B in buffer A over 15 min, followed by a linear gradient of 35–53% buffer
B in buffer A over 12 min. Cold toxin was observed to elute at 19 min
(i.e. during the last minute of the second gradient); monoiodinated toxin
was observed to elute at 21–22 min. Hereinafter, the radiolabeled swap
mutant will be referred to as 125I--ACTX-Hv1a.
Preparation of Cockroach Neuronal Membranes—Neuronal mem-
branes were prepared from the heads of adult P. americana as described
previously (15), except that the final Ficoll centrifugation step was
eliminated. The concentration of membrane proteins in the final prep-
aration was determined using a Bradford protein assay (Bio-Rad) with
bovine serum albumin as a standard.
Competitive Binding Assays using Radiolabeled -ACTX-Hv1a—
Equilibrium competition binding experiments were performed using
increasing concentrations of unlabeled mutant toxin in the presence of
a fixed concentration of 125I--ACTX-Hv1a. Individual binding reac-
tions were brought to a final volume of 100 l in binding buffer (75 mM
NaCl, 5 mM CaCl2, 50 mM HEPES, and 0.1% bovine serum albumin, pH
7.4). Cockroach neuronal membranes were added to binding reactions
to a final concentration of 0.15 g of membrane protein/l. 125I--
ACTX-Hv1a was added to a final concentration of 1–1.5 nM. Unlabeled
competitors were present at various final concentrations. After incuba-
tion at room temperature for 60 min, the reactions were terminated by
dilution with 2 ml of ice-cold wash buffer (300 mM choline chloride, 5 mM
CaCl2, 50 mM HEPES, and 0.1% bovine serum albumin, pH 7.4). Bound
toxin was recovered from the diluted reactions using rapid vacuum
filtration through GF/C filters (Whatman) preincubated in 0.3% poly-
ethylenimine (Sigma-Aldrich). The filters were then rapidly washed
three times with 2 ml of wash buffer. Nonspecific toxin binding was
determined in the presence of 10  unlabeled -ACTX-Hv1a and
typically comprised 40–50% of total binding. Counts of the washed
filters were analyzed using KaleidaGraph (Abelbeck/Synergy, Reading,
PA) to fit data to a non-linear Hill equation for IC50 determination. Ki
values were calculated using the Cheng-Prusoff equation (which as-
sumes pure competition at a single site), Ki  IC50/[1  (L*/Kd)], where
L* is the concentration of radiolabeled toxin and Kd is its dissociation
constant (16). The Kd value used for these computations was obtained
by using the computer program LIGAND (Elsevier Biosoft) to perform
iterative Scatchard analysis on data from competition binding experi-
ments performed with 125I--ACTX-Hv1a and unlabeled wild-type
-ACTX-Hv1a.
Patch-clamp Recordings—Human embryonic kidney (HEK) tsA-201
cells were grown and transfected with cDNAs encoding 1, 2-, and 
subunits of rat HVA calcium channels as described previously (17).
Whole-cell patch-clamp recordings were acquired from the transiently
transfected tsA-201 cells as described previously (17).
RESULTS
Alanine-scanning Mutagenesis of -ACTX-Hv1a—We ex-
panded a collection of described previously alanine mutants of
-ACTX-Hv1a (11) to give a larger panel of 28 mutants that
comprised individual alanine mutations at all positions corre-
sponding to solvent-exposed non-glycine sidechains of the
toxin. The six cysteine residues that form the toxin’s cystine-
knot motif (2, 10) were excluded from the mutational analysis
because their side chains are involved in disulfide bonds that
are critical to the three-dimensional structure of the toxin. Ile5
was excluded because it forms part of the buried hydrophobic
core of the toxin (2) and is likely to be critical for toxin folding.
Gly8 and Gly30 were also excluded because they are located in
-turns that are likely to be structurally important (2). More-
over, with only a hydrogen atom side chain, the Gly residues
are unlikely to be functionally important. The P6A and S19A
mutant toxins were difficult to overexpress and purify, and
were therefore not used in the fly toxicity assays.
Structural Integrity of Mutant Toxins—Although the muta-
tions that we introduced into -ACTX-Hv1a were chosen to avoid
major structural perturbations, it was important to test this
experimentally. We did this by acquiring CD spectra of the WT
and mutant recombinant toxins. The CD spectrum of WT toxin
exhibits a  sheet signature (Fig. 1A) with pronounced minima
and maxima at 210 and 196 nm, respectively (11); this is consist-
ent with a 16-residue  hairpin (residues 22–37) being the major
secondary structure feature of -ACTX-Hv1a (2) (see Fig. 1C).
The small positive band at 236 nm is presumably caused by the
aromatic chromophore of Tyr13, since this feature is absent in CD
spectra of Y13A and Y13L mutants but present (albeit slightly
blue-shifted) in the spectrum of a Y13W mutant (Fig. 1B).
We showed previously that none of the alanine-scan mutants
in the -hairpin region of the toxin were structurally perturbed
except for mutations at Lys34 (11). Likewise, the CD spectrum
of 13 of the 15 newly constructed alanine mutants in the
disulfide-rich globular portion of the toxin superimposed
closely on the CD spectrum of the WT recombinant toxin, as
illustrated for the S1A and Q9A mutants in Fig. 1A. Only the
CD spectra of the Y13A and N16A mutants differed signifi-
cantly from that of the WT toxin. The CD spectrum of the Y13A
mutant was similar to that of the WT toxin except that the
Tyr13 side chain signature at 236 nm was absent as expected
(Fig. 1B). We conclude that the backbone fold of the Y13A
mutant is similar to that of the native toxin.
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We were surprised to find that the presumed Tyr13 side
chain signature was also absent in the N16A mutant (Fig. 1A).
This suggests that the conformation of this mutant is per-
turbed in a manner that significantly alters the chemical en-
vironment of the Tyr13 side chain chromophore. Asn16 lies
within a rare triple turn motif formed by three overlapping
type I  turns (residues 13–16, 14–17, and 17–20) (2). Asn16 is
found at the i2 position of the second turn, where Asn and
Asp are by far the most favored residues (18). In contrast,
alanine is one of the least favored residues at this position in
type I  turns (18). Thus, an N16A mutation might abrogate
this  turn, thereby disrupting the entire set of interconnected
 turns in the triple turn system and substantially altering the
environment of the Tyr13 side chain. We therefore suspect that
the small reduction in cricket toxicity observed for the N16A
mutant (see below) is the result of a perturbation of the toxin
structure in the region of the triple turn (residues 13–20).
However, for all other alanine mutants, we can rule out the
possibility that functional defects are caused by major struc-
tural perturbations.
Cricket Bioassays—The insecticidal potency of each mutant
was initially examined by comparing its LD50 in a model or-
thopteran (house crickets) with that of WT recombinant toxin
(Fig. 1D). Based on the reasoning described previously (11), we
considered mutated residues to be functionally significant if
the LD50 of the mutant toxin was more than 4-fold greater than
that of WT toxin, potentially significant if the corresponding
LD50 was 2–4-fold greater than that of WT toxin, or otherwise
insignificant. We were surprised to find, based on these crite-
ria, that only Gln9 and Pro10 were identified as functionally
significant residues for activity against crickets (Fig. 1D), in
addition to the -hairpin residues Asn27 and Arg35 that were
identified in our previous structure-activity relationship study
(11). Residues Tyr13 and Asn16 were identified as potentially
significant for cricket toxicity (Fig. 1D).
Fly Bioassays—We expanded the toxicity assays to include a
model dipteran (house flies) for several reasons. First, dipter-
ans are the most pernicious insects from a human and animal
health perspective, being responsible for the transmission of
malaria, filariasis, trypanosomiasis, leishmaniasis, and nu-
merous arboviral diseases (4, 7). Thus, it was of interest to
establish whether -ACTX-Hv1a might serve as a lead for
FIG. 1. Mapping the insect-active
epitope of -ACTX-Hv1a using ala-
nine-scanning mutagenesis. Compari-
son of the CD spectrum of WT recombi-
nant -ACTX-Hv1a with S1A, Q9A, and
N16A mutants (A) and Y13A, Y13L, and
Y13W mutants (B). C, secondary struc-
ture of -ACTX-Hv1a as determined from
NMR structural studies (2). Sage boxes
represent  turns (labeled 1–5), whereas
the two  strands that comprise the tox-
in’s  hairpin are shown as blue arrows.
D, histogram showing the -fold increase
in LD50 in crickets (Acheta domestica) for
each alanine mutation. E, histogram
showing the-fold-increase in LD50 in flies
(Musca domestica) for each alanine muta-
tion. F, histogram showing the-fold-in-
crease/decrease in Ki for binding of each
alanine mutant to cockroach (Periplaneta
americana) neuronal membranes. The in-
set shows representative binding curves
for WT toxin and Q9A, N27A, and R35A
mutants.
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development of insecticides directed against dipteran vectors of
human disease. Second, although some venomous animals such
as cone snails are specialist predators, spiders are mostly gen-
eralists that prey on a wide range of invertebrates and some-
times small vertebrates. Thus, there would be selective advan-
tage for spiders that evolved venoms capable of dealing with
subtle variations in ion channel targets between different in-
sects, in addition to the intraspecific complexity introduced by
the high degree of differential splicing and editing of tran-
scripts encoding channel subunits (19, 20). One evolutionary
response to this problem seems to have been lineage-specific
gene duplication events that created a suite of closely related
paralogous toxins (21). However, an alternative possibility is
that a single toxin encodes both a core pharmacophore that is
crucial for interaction with the target plus additional residues
that are critical contributors to channel binding in some insect
species but not others. To address this latter possibility, we
sought to examine whether the insect-active epitope of
-ACTX-Hv1a was invariant between two highly divergent
insect orders (i.e. Diptera and Orthoptera) or whether certain
residues might be important for activity in one of these orders
but not the other.
Finally, we were surprised that the cricket toxicity assays
seemed to indicate that the insect-active epitope of -ACTX-
Hv1a comprises only a few residues, thus raising the possibility
that variations in toxin bioavailability/pharmacokinetics might
be masking variations in channel-blocking activity of the mu-
tant toxins. That is, in the LD50 assays, the activity of a toxin
depends not only on its intrinsic affinity for the target channel
but also on its in vivo stability and its ability to penetrate
anatomical barriers. The latter point is crucial in that -ACTX-
Hv1a targets the central nervous system of insects (4, 5),
whereas most other spider toxins act presynaptically at insect
neuromuscular junctions. Thus, a mutant toxin might have
reduced activity not because of a reduced affinity for the target
channel, but rather because of increased susceptibility to pro-
teolysis or more limited access to the central nervous system.
We anticipated that these potential problems would be less
critical in the smaller house flies as they responded more
rapidly than crickets to toxin injection, suggesting that ana-
tomical barriers are less critical, and they were about 3-fold
more sensitive to the toxin (LD50  86.5  1.3 pmol/g) than
crickets (LD50  269  13 pmol/g).
Fig. 1E shows the insecticidal potency of each alanine mu-
tant in house flies relative to the activity of the WT recombi-
nant toxin. As for the cricket bioassays, residues Pro10, Asn27,
and Arg35 were found to be functionally critical; each individual
mutation caused a 10–20-fold reduction in LD50. In contrast,
Gln9 and all residues identified as potentially significant in the
cricket assays (Tyr13, Asn16, Asn29, Lys34, and Asp37) seemed
unimportant for activity against flies. An N27A,R35A double-
mutant toxin (11) that carried mutations in two of the three
residues most critical for insecticidal activity had a 60-fold
higher LD50 in house flies than WT recombinant toxin (data
not shown).
Competitive Binding Assays—We developed a competitive
binding assay to study the interaction between -ACTX-Hv1a
and its presumed calcium channel target in a manner not
complicated by issues of pharmacokinetics and bioavailability.
This assay measured the ability of cold -ACTX-Hv1a and
alanine mutants thereof to displace the radiolabeled tracer
125I--ACTX-Hv1a from neuronal membranes prepared from
the heads of adult cockroaches.
The assay was complicated by what seemed to be very high
and inconsistent nonspecific binding of 125I--ACTX-Hv1a to
the membrane preparation, a problem that could not be re-
solved through any modification of the assay conditions tested
(i.e. using more or less toxin per binding reaction, more or less
membrane preparation per binding reaction, additional
washes, etc.). We presume this problem stems from two issues:
1) the low total number of -ACTX-Hv1a binding sites (Bmax 
0.5–1.0 pmol/mg), consistent with the expected low density of
voltage-gated calcium channels in excitable membranes (22); 2)
the relatively low affinity of the tracer (Kd  5 nM, see below).
In contrast with -ACTX-Hv1a, the scorpion toxin Bj-xtrIT
binds to cockroach neuronal membranes with Kd  148 pM and
Bmax  3 pmol/mg (23). The low receptor density and relatively
low affinity of -ACTX-Hv1a for these receptors necessitated
the use of large amounts of membrane for each binding reaction
and a relatively high concentration (1–1.5 nM) of radioactive
tracer. Nevertheless, in most cases, we obtained binding curves
that did not appear disrupted by inconsistent background and
which could be analyzed to yield reliable Ki values (see inset to
Fig. 1F for examples of typical binding curves).
Scatchard analysis indicated that the Kd of the toxin for
cockroach neuronal membranes was 5 nM (n  4). Although
much lower than the affinity of Bj-xtrIT for cockroach neuronal
membranes, the Kd is similar to that estimated for the scorpion
toxin Lqh III under similar conditions (15). The Kd estimate
was used with the Cheng-Prusoff equation under “Experimen-
tal Procedures” to calculate the fold increase/decrease in Ki for
each mutant (Fig. 1F). Mutation to alanine of any of the three
residues critical for toxicity against both crickets and flies (i.e.
Pro10, Asn27, and Arg35) reduced the Ki by more than 150-fold,
with the R35A mutation causing a dramatic 280-fold reduction
in binding affinity (Fig. 1F). The Q9A mutation, which reduced
activity against crickets but not flies, caused a moderate 16-
fold increase in Ki, as did the Y13A mutation (Fig. 1F). No other
mutations significantly affected the binding of -ACTX-Hv1a
to cockroach neuronal membranes. Thus, as observed in a
previous study of scorpion  neurotoxins (24), there seems to be
a good correspondence between the results of the binding and
lethality assays. Differential bioavailability of mutants does
not seem to be a major complicating factor in the LD50 assays,
except perhaps for the R35A mutation, which was significantly
more deleterious in binding studies than in lethality assays.
Chemical Features of the Toxin Pharmacophore—The ala-
nine scanning mutagenesis studies indicated that Pro10, Asn27,
and Arg35 are the key components of the toxin pharmacophore;
Gln9 and Tyr13 are of minor importance in orthopteroids (crick-
ets and cockroaches) but unimportant in dipterans (see Fig. 1).
By using a panel of non-alanine mutants, we showed previously
that the -NH2 group of Asn
27 most probably donates a hydro-
gen bond to an acceptor on the target calcium channel, whereas
the -guanido group of Arg35 most likely forms an ion pair with
a carboxylate group on the channel (11). We decided to probe
the chemical features of Gln9 and Tyr13 to ascertain the nature
of their interaction with orthopteroid calcium channels. CD
analysis of toxins with mutations at Tyr13 (Fig. 1B) and Gln9
(data not shown) indicated that their structures were similar to
that of WT toxin.
A Y13F mutant was almost equipotent with native toxin in
the cricket bioassay (Fig. 2A), which suggests that the hydroxyl
group is relatively unimportant and that this residue mainly
contacts the channel via hydrophobic interactions involving the
aromatic ring. Consistent with this hypothesis, replacement of
Tyr13 with leucine, a similarly sized hydrophobic, non-aromatic
side chain, yielded a mutant toxin (Y13L) that had toxicity
similar to that of the Y13F and native toxins. In contrast,
replacement of Tyr13 with either a much smaller alanine resi-
due (Y13A) or a significantly larger tryptophan residue (Y13W)
caused a 3–4-fold reduction in LD50 (Fig. 2A). We conclude that
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Tyr13 makes contacts with a hydrophobic pocket in the channel
that cannot be readily accessed by significantly smaller or
larger hydrophobic sidechains at this position.
A Q9E mutant was about 50% less toxic to crickets than a
Q9A mutant and had a 6-fold lower LD50 than WT toxin (Fig.
2B). It is impossible to determine from these data alone
whether the loss of -NH2 group, the introduction of a negative
charge, or a combination of these factors is responsible for the
large reduction in activity caused by the Q9E mutation. The
data suggest, however, that the Gln9 side chain carbonyl group,
which is retained in the Q9E mutant, does not make critical
hydrogen bond interactions with the target channel. A Q9N
mutation (2.4-fold reduction in LD50) was significantly less
deleterious than a Q9A mutation (4-fold reduction in LD50)
(Fig. 2B). We interpret these results to indicate that the -NH2
of Gln9 makes hydrogen-bond interactions with acceptor
groups on the channel and that this interaction can be retained
to some degree when Gln9 is replaced by the slightly smaller
Asn, in which the side chain is 1.5 Å shorter.
Effect of -ACTX-Hv1a on Vertebrate Calcium Chan-
nels—We tested the effect of -ACTX-Hv1a and a functionally
defective N27A,R35A double-mutant toxin on whole-cell cal-
cium currents recorded from HEK cells that transiently ex-
pressed rat Cav2.1, Cav2.2, or Cav1.2 calcium channels. At a
concentration of 10 M, neither -ACTX-Hv1a nor the double-
mutant toxin had any observable effect on calcium currents
carried by these channels (data not shown). However, at a
concentration of 30 M, the WT toxin partially antagonized all
three channel subtypes; the strongest inhibition was observed
against Cav1.2 channels (Fig. 3). Remarkably, the inhibition of
Cav2.1 and Cav2.2 currents was slightly enhanced in the dou-
ble-mutant toxin, whereas the current block was marginally
reduced for the Cav1.2 subtype. The fact that the moderate
current block at this extremely high toxin concentration is not
abrogated by the double mutation suggests that the weak in-
hibition of rat HVA calcium channels relies on structural de-
terminants that are uniquely different from those involved in
block of insect calcium channels.
DISCUSSION
Calcium Channels as Insecticide Targets—Peptidic calcium
channel blockers have been isolated from the venoms of numer-
ous spiders, including plectoxin II from Plectreurys tristes,
CSTX-1 from the subtropical wandering spider Cupiennius
salei, several families of -agatoxins from the American funnel-
web spider Agelenopsis aperta, and two families of -atracotox-
ins from various species of Australian funnel-web spiders (gen-
era Atrax and Hadronyche) (7). The evolution of calcium
channel blockers in spider venoms as part of a mechanism for
incapacitating envenomated prey is not surprising because
voltage-gated calcium channels (VGCCs) play critical roles in
modulating synaptic transmission in insects. The essential role
of insect VGCCs is highlighted by the fact that the D. melano-
gaster genome appears to encodes pore-forming 1-subunits for
only one Cav1 family member (Dmca1D) and one Cav2 family
member (Dmca1A/cacophony) (25), and severe loss-of-function
mutations in either of these genes is embryonic lethal (26–28).
Despite the fact that insect VGCCs seem to be excellent
insecticide targets, as first suggested almost a decade ago (29),
no commercial insecticides have ever been directed against
these channels. The limited phyletic specificity of the -agatox-
ins may have promoted the misconception that insect VGCCs
could not be selectively targeted. However, this view is at odds
with the fact that insect and vertebrate VGCCs are pharmaco-
logically distinct, with different susceptibilities to a range of
peptide toxins and chemical agents (30). Our recent isolation of
two families of highly insect-selective -atracotoxins (4, 10)
demonstrates that phyletically specific targeting of insect
VGCCs is indeed possible. This is further exemplified in the
current study, where we demonstrated that -ACTX-Hv1a is
lethal to a range of insect species but inactive against heter-
ologously expressed rat HVA VGCCs even at concentrations as
high as 10 M.
The Insect-specific Pharmacophore of -ACTX-Hv1a—The
specificity of -ACTX-Hv1a for insect VGCCs makes it an ex-
cellent lead for the development of insecticides directed against
insect calcium channels. In this study, we mapped the phar-
macophore of -ACTX-Hv1a to provide a template for rational
design of such insecticides. The cockroach neuronal membrane
binding assays and the two sets of insect bioassays all identi-
fied three functionally critical residues (Pro10, Asn27, and
Arg35; see Fig. 1, D–F) that we presume correspond to the
primary VGCC-binding epitope of the toxin. It is remarkable
that these residues, although well separated in the amino acid
sequence, form a spatially contiguous epitope when mapped
onto the three-dimensional structure of -ACTX-Hv1a (Fig.
4A). Arg35 is positioned at the center of this binding “hot spot,”
flanked by Pro10 and Asn27.
Arg is one of the most highly enriched residues at protein-
protein interfaces (31), and Arg35 seems to be the most critical
residue for binding of -ACTX-Hv1a to cockroach VGCCs; mu-
tation of Arg35 to Ala caused a 280-fold reduction in Ki (see Fig.
1F), which corresponds to a change in the free energy of binding
(Gbind) of 3.3 kcal/mol. Mutation of the flanking Pro
10 and
Asn27 residues to Ala caused a smaller 180-fold reduction in
Ki, corresponding to a Gbind of3.1 kcal/mol. Gln
9 and Tyr13
seem to be of minor importance for binding of the toxin to
orthopteroid VGCCs, with mutation of these residues to Ala
giving a Gbind of only 1.6 kcal/mol. Gln
9 is contiguous with
the core pharmacophore, whereas the Tyr13 side chain is situ-
ated 12 Å from the binding hot spot (Fig. 4A). These residues
do not seem to be important for binding of the toxin to
dipteran VGCCs.
Sequencing of venom peptides (1, 3) and analysis of venom-
gland cDNA libraries (4, 21) has revealed that each species of
Australian funnel-web spider typically expresses a complement
of 3–6 -ACTX-Hv1a homologs in its venom. Despite signifi-
cant intra- and interspecific variations in the sequences of
these homologs, the five pharmacophore residues (Gln9, Pro10,
Tyr13, Asn27, and Arg35) are identical in all -ACTX-1 orthologs
that have been sequenced to date (see Fig. 3A in Ref. 4 for an
alignment of 11 representative -ACTX-1 sequences). Thus,
the data currently available seem to indicate that the pharma-
cophore of -ACXT-Hv1a has been universally conserved in
this family of spiders.
FIG. 2. Probing chemical features of the toxin pharmacophore.
Histogram showing the-fold-increase in LD50 in crickets (Acheta domes-
tica) for various point mutations at residues Tyr13 (A) and Gln9 (B). The
first bar in each histogram corresponds to WT toxin.
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FIG. 4. The pharmacophore of
-ACTX-Hv1a. A, molecular surface of
-ACTX-Hv1a (Protein Data Base file
1AXH; (2)) with core pharmacophore res-
idues (Pro10, Asn27, and Arg35; Gbind 
2.5 kcal/mol) shown in red. Residues
drawn in orange (Gln9 and Tyr13; Gbind
1.6 kcal/mol) are of minor importance
for binding to orthopteroid VGCCs but
seem to be unimportant for interaction of
the toxin with dipteran calcium channels.
Proposed molecular interactions with or-
thopteroid calcium channels are summa-
rized above each double-headed arrow.
Gbind values, which indicate the loss of
binding energy (in kilocalories per mole)
resulting from mutation of the indicated
residue to Ala, were calculated using the
equation Gbind  RTln(wild-type Ki/
mutant Ki). B, molecular surface of
-conotoxin MVIIA (Protein Data Base
file 1OMG; (48)) with key pharmacophore
residues shown in red (Gbind 2.5 kcal/
mol) and orange (Gbind  1.8–2.2 kcal/
mol). Gbind values resulting from mu-
tation of the indicated residues to Ala
were calculated from IC50 values reported
in Ref. 36. The illustrated mimetic of
-conotoxin MVIIA, which was rationally
designed to mimic three key pharmacoph-
ore residues (Arg10, Leu11, and Tyr13), had
an IC50 of3 M against rat Cav 2.2 chan-
nels (46). Molecular surfaces were drawn
using PyMOL (49).
FIG. 3. Effect of -ACTX-Hv1a on rat HVA calcium channels. A, whole-cell calcium current recordings showing the effect of 30 M wild-type
-ACTX-Hv1a on currents carried by rat HVA calcium channels transiently expressed in HEK cells. B and C, extent of current blockage for each
channel subtype caused by either 30 M -ACTX-Hv1a (B) or a functionally defective double mutant toxin carrying N27A and R35A mutations (C).
Toxins were applied to transfected HEK cells in 20 mM Ba2 recording solution at a holding potential of 	100 mV. Test currents were elicited by
voltage stepping to 20 mV. Data are the average of recordings from six cells.
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Comparison of the -ACTX-Hv1a Pharmacophore with
VGCC-binding Epitopes on Other Toxins—As far as we are
aware, the only other toxin VGCC-binding epitopes that have
been mapped in detail are those on the functionally homologous
cone snail toxins -conotoxin GVIA (32–34) and -conotoxin
MVIIA (35, 36). Extensive mutagenesis of these -conotoxins,
which selectively block HVA currents carried by vertebrate CaV
2.2 (N-type) VGCCs, revealed a more extensive, discontinuous
pharmacophore than we elucidated in this study for -ACTX-
Hv1a (see Ref. 37 for a review). That is, although the three
residues that form the core pharmacophore of -ACTX-Hv1a
(i.e. Pro10, Asn27, and Arg35) are spatially contiguous (Fig. 4A),
the three key residues in the pharmacophore of -conotoxin
MVIIA (i.e. Lys2, Leu11, and Tyr13) are discontinuous and their
sidechains are separated from one another (as measured using
the C atoms) by 7–15 Å (Fig. 4B). Moreover, in contrast with
-ACTX-Hv1a, scanning mutagenesis of both -conotoxin
GVIA and -conotoxin MVIIA revealed numerous residues that
make minor contributions to channel binding (Gbind 
 1.6
kcal/mol) (37).
The -ACTX-Hv1a pharmacophore cannot be superimposed
on a subset of the key VGCC-binding residues in either of the
-conotoxins, consistent with our observation that physiologi-
cal concentrations of -ACTX-Hv1a do not block HVA currents
carried by heterologously expressed rat CaV 2.2 channels. Lys
2
and Tyr13 are the two most critical residues for block of verte-
brate CaV 2.2 channels by the -conotoxins, but these residue
types are not even present in the primary -ACTX-Hv1a phar-
macophore. We conclude that the -conotoxins and -ACTX-
Hv1a make markedly different types of interactions with their
cognate calcium channel targets.
Using -ACTX-Hv1a as a Template for Mimetic Design—
Heterologous expression of the cognate calcium channel target
of -ACTX-Hv1a in an easily manipulated cell line could be
exploited to develop high throughput screens of chemical li-
braries to uncover lead chemical insecticides based on the mode
of action of -ACTX-Hv1a. Although high-throughout screen-
ing has become a dominant paradigm in the pharmaceutical
industry, it typically produces few viable leads; despite the
impressive size of many compound libraries, they are often
limited in pharmacophore diversity (38). Indeed, although
chemical libraries have become a critical part of the lead iden-
tification process in insecticide and pharmaceutical discovery,
about two-thirds of all 1031 newly approved drugs in the period
1983–2002 were either natural products or compounds derived
from natural products (39). Many of the most successful insec-
ticidal compounds have also been derived from natural prod-
ucts, including the pyrethroids, spinosads, avermectins, and
Bacillus thuringiensis -endotoxins (40). Thus, a potentially
rewarding alternative to high throughput screens based on
heterologous expression of the target of -ACTX-Hv1a is ratio-
nal design of insecticides based on the toxin’s pharmacophore.
In recent years, there have been several impressive exam-
ples of rational design of small molecules based on mimicry of
protein-binding epitopes, a process we refer to as “pharmacoph-
ore cloning” (41, 42). For example, Genentech recently designed
small molecules that mimic the complicated but spatially con-
tiguous LFA-1 binding epitope on intercellular adhesion mole-
cule-1 (43). More relevant to the current discussion are three
recent studies in which attempts were made to clone the phar-
macophores of peptide toxins that block vertebrate calcium or
potassium channels (44–46). In the most successful study, the
pharmacophore of -conotoxin MVIIA was mimicked by deco-
rating an alkylphenyl backbone with chemical groups corre-
sponding to three key functional residues (Arg10, Leu11, and
Tyr13) identified in an alanine scan (Fig. 4B). Even though, as
discussed above, the pharmacophore of -conotoxin MVIIA is
discontinuous and other residues such as Lys2 are known to be
involved in the toxin-channel interaction, the rationally de-
signed nonpeptide mimetics had IC50 values of 3 M against
human N-type VGCCs (46). Although native -conotoxin
MVIIA binds these channels with considerably higher sub-
nanomolar affinity (35–37), the rationally designed mimetics
nevertheless have sufficient affinity to make them desirable
leads for further optimization as antinociceptive agents (46).
As far as we are aware, there is no precedent for synthetic
imitation of the pharmacophore of an insecticidal peptide toxin
with the aim of developing an insecticide. The primary reason
for this is presumably lack of suitable design templates. To
date, besides -ACTX-Hv1a, the pharmacophores have been
mapped for only three other insect-selective toxins: J-ACTX-
Hv1c from the Australian funnel-web spider Hadronyche ver-
suta (47) and insecticidal neurotoxins from the scorpions Leiu-
rus quinquestriatus hebraeus (LqhIT) (24) and Buthotus
judaicus (Bj-xtrIT) (23). -ACTX-Hv1a most likely presents a
best case scenario for rational insecticide design because this
peptide is about half the size of the scorpion toxins, and its
pharmacophore is much less complicated. The core -ACTX-
Hv1a pharmacophore (i.e. residues Pro10, Asn27, and Arg35)
corresponds to a contiguous surface area of 200 Å2, which
approximates the typical solvent-accessible surface area (150–
500 Å2) of a small drug (41). In contrast, the pharmacophore of
Bj-xtrIT encompasses a discontinuous surface area of 1405 Å2
(23), which represents a much more difficult template for de-
sign of nonpeptide mimetics.
It is hoped that the mapped pharmacophore of -ACTX-Hv1a
will facilitate development of a new rational design paradigm
in insecticide discovery. However, a key question that remains
to be addressed is whether a rationally designed nonpeptide
mimetic can maintain the remarkable and highly desirable
phyletic specificity of the parent peptide toxin. Residues
deemed not to be functionally important according to insect
functional studies might nevertheless provide a steric impedi-
ment to binding to the vertebrate counterpart of the targeted
insect channel. Failure to consider this might lead to phyleti-
cally indiscriminate mimetics with an unacceptable toxicolog-
ical profile.
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